The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, Sony Reader...
Most popular at the top
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes, 3
Springer 2009; US$ 129.99Neuropsychiatric disorders such as schizophrenia, mood disorders, Alzheimer's disease, epilepsy, alcoholism, substance abuse and others are some of the most debilitating illnesses worldwide. This book offers a synthesis of knowledge about diverse topics of the biomarker and endophenotype strategies in neuropsychiatry. more...
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes, 4
Springer 2009; US$ 129.99Neuropsychiatric disorders such as schizophrenia, mood disorders, Alzheimer's disease, epilepsy, alcoholism, substance abuse and others are one of the most debilitating illnesses worldwide. This book offers a synthesis of knowledge about diverse topics of the biomarker and endophenotype strategies in neuropsychiatry. more...
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes, 2
Springer 2009; US$ 129.99Offers a synthesis of the knowledge about diverse topics of the biomarker and endophenotype strategies in neuropsychiatry. This four-volume handbook is suitable for a broad spectrum of readers including neuroscientists, psychiatrists, neurologists, endocrinologists, pharmacologists, clinical psychologists, general practitioners, and geriatricians. more...
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes, 1
Springer 2009; US$ 129.99Offers a synthesis of the knowledge about diverse topics of the biomarker and endophenotype strategies in neuropsychiatry. This book is suitable for neuroscientists, psychiatrists, neurologists, endocrinologists, pharmacologists, clinical psychologists, general practitioners, and geriatricians. more...
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Springer 2010; US$ 219.99Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive... more...
Handbook of Schizophrenia Spectrum Disorders, Volume I
Springer 2011; US$ 149.99A few disorders have some of the same symptoms as schizophrenia including schizoaffective disorders, schizophreniform disorder, schizotypal and schizoid personality disorders, delusional disorder, and autism (schizophrenia spectrum disorders). Since the 2000 there has been significant progress in our understanding of the early presentations, assessment,... more...
Handbook of Schizophrenia Spectrum Disorders, Volume II
Springer 2011; US$ 149.99A few disorders have some of the same symptoms as schizophrenia including schizoaffective disorders, schizophreniform disorder, schizotypal and schizoid personality disorders, delusional disorder, and autism (schizophrenia spectrum disorders). Since the 2000 there has been significant progress in our understanding of the early presentations, assessment,... more...
Handbook of Schizophrenia Spectrum Disorders, Volume III
Springer 2011; US$ 149.99A few disorders have some of the same symptoms as schizophrenia including schizoaffective disorders, schizophreniform disorder, schizotypal and schizoid personality disorders, delusional disorder, and autism (schizophrenia spectrum disorders). Since the 2000 there has been significant progress in our understanding of the early presentations, assessment,... more...
Polypharmacy in Psychiatry Practice, Volume II
Springer 2013; US$ 169.99Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in... more...
Polypharmacy in Psychiatry Practice, Volume I
Springer 2013; US$ 169.99Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in... more...









